{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:53:27Z","timestamp":1768096407109,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Cervical cancer metastatic to the para-aortic lymph nodes (PALNs) carries a poor prognosis. Despite extended-field radiation therapy (EFRT), only 30% to 50% of patients will survive 3 years. We sought to examine the treatment regimens used, associated toxicities, and treatment outcomes in patients with cervical cancer metastatic to PALN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective review was performed of all patients with cervical cancer treated at a single institution between January 1, 2007 and November 1, 2014. Included patients had PALN metastases as the most distant site of disease, and all treatment plans were designated as curative. Excluded patients had other distant disease or treatment plans considered palliative. Standard treatment consisted of EFRT with concurrent platinum-based chemotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifty-one of 344 patients (14.8%) fulfilled the inclusion criteria. The median age was 48.4 years. Forty-four patients received standard EFRT; 7 also received adjuvant platinum\/taxane chemotherapy. Thirty-nine of 51 (76%) of patients achieved a complete response to primary treatment. Twelve of 51 (24%) had persistent disease or progression at the completion of treatment. Of responders, 15 of 39 (38%) recurred for an overall treatment failure rate of 27 of 51 (53%). Nineteen of 27 (70%) of treatment failures occurred outside the radiated field. Adjuvant chemotherapy following EFRT was not predictive of progression-free survival or overall survival. PALN diameter \u22651\u2009cm was a significant negative prognostic indicator for overall survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Over half of patients with cervical cancer metastatic to the PALN failed extended-field chemoradiation. Most failures occurred outside the radiated field suggesting PALN involvement is a surrogate marker of systemic disease. These findings underscore the need for effective systemic therapy, especially in patients with PALN \u22651\u2009cm in size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000458","type":"journal-article","created":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T01:19:31Z","timestamp":1526779171000},"page":"1225-1230","source":"Crossref","is-referenced-by-count":17,"title":["The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer"],"prefix":"10.1097","volume":"41","author":[{"given":"Dustin B.","family":"Manders","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}]},{"given":"Travis T.","family":"Sims","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"}]},{"given":"April","family":"Bailey","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"},{"name":"Radiology"}]},{"given":"Lindsay","family":"Hwang","sequence":"additional","affiliation":[{"name":"Radiology"}]},{"given":"Debra L.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}]},{"given":"David S.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}]},{"given":"Siobhan M.","family":"Kehoe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}]},{"given":"Kevin V.","family":"Albuquerque","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX"}]},{"given":"Jayanthi S.","family":"Lea","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L","article-title":"Carcinoma of the cervix treated with radiation therapy I: a multi-variate analysis of prognostic variables in the gynecologic oncology group","volume":"67","author":"Stehman","year":"1991","journal-title":"Cancer"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0090-8258(84)90151-3","article-title":"Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes: a gynecologic oncology group study","volume":"19","author":"Berman","year":"1984","journal-title":"Gynecol Oncol"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0360-3016(98)00267-3","article-title":"Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group Study","volume":"42","author":"Varia","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2008.09.035","article-title":"A phase I\/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study","volume":"112","author":"Walker","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ijrobp.2007.01.026","article-title":"Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116","volume":"68","author":"Small","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0360-3016(01)01723-0","article-title":"Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes","volume":"51","author":"Grigsby","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0360-3016(98)00132-1","article-title":"Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the radiation therapy oncology group 92-10","volume":"41","author":"Grigsby","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/11534370-000000000-00000","article-title":"Pharmacotherapy options for locally advanced and advanced cervical cancer","volume":"70","author":"Duenas-Gonzalez","year":"2010","journal-title":"Drugs"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2003.12.038","article-title":"Lymph node control in cervical cancer","volume":"59","author":"Grigsby","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","article-title":"Carcinoma of the cervix uteri","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiol.2541090361","article-title":"Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging","volume":"254","author":"McMahon","year":"2010","journal-title":"Radiology"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201812000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:00:25Z","timestamp":1693713625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201812000-00014"}},"subtitle":["An Institutional Experience"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000458","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}